AI assistant
AGENUS INC — Director's Dealing 2015
Sep 29, 2015
34023_dirs_2015-09-29_441e6ae2-32d2-4d13-9787-fc508ad1b0c5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2015-09-25
Reporting Person: ARMEN GARO H (Chairman & CEO)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1309607 | Direct |
| Common Stock | 304046 | Indirect |
Footnotes
F1: The original Form 4 was filed in error and should be disregarded. Dr. Armen did not acquire additional shares or dispose of shares on the date reported. The holdings reflected on Table I of this amendment to the Form 4 were taken from the Dr. Armen's last Form 4 dated June 27, 2014 and are being reported for the purpose of accessing the filing system.
F2: Dr. Armen is trustee and has investment authority for the Garo Armen 2014 2 Year GRAT holding 300,000 shares of Agenus Inc. common stock. Dr. Armen disclaims beneficial ownership. Dr. Armen is also Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims beneficial ownership to the extent of his pecuniary interest therein.